Literature DB >> 16987885

Type-2 diabetes: a cocktail of genetic discovery.

H Freeman1, R D Cox.   

Abstract

Diabetes is one of the most challenging health problems of the 21st century with an alarming increase in the prevalence of type-2 diabetes mellitus (T2DM) and associated conditions such as hypertension, dyslipidemias and obesity. T2DM is a complex genetic disease comprised of many metabolic disorders with a common phenotype of glucose intolerance. Patients with T2DM would have inherited a variety of different genetic factors that together with environmental factors combine as the primary cause. This complicates the genetic study of the disease and means that different methodological approaches are needed if we hope to identify susceptibility genes and genetic variants. The biochemical and physiological processes that underpin T2DM are still unclear although most certainly involve impairment in insulin secretion and insulin action. In this review, we will discuss the most exciting advances in understanding the genetics of T2DM by looking at recent discoveries employing human association studies and candidate genes arising from animal models.

Entities:  

Mesh:

Year:  2006        PMID: 16987885     DOI: 10.1093/hmg/ddl191

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Prep1 deficiency induces protection from diabetes and increased insulin sensitivity through a p160-mediated mechanism.

Authors:  Francesco Oriente; Luis Cesar Fernandez Diaz; Claudia Miele; Salvatore Iovino; Silvia Mori; Victor Manuel Diaz; Giancarlo Troncone; Angela Cassese; Pietro Formisano; Francesco Blasi; Francesco Beguinot
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

2.  IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes.

Authors:  S Rodriguez; G Eiriksdottir; T R Gaunt; T B Harris; L J Launer; V Gudnason; I N M Day
Journal:  Growth Horm IGF Res       Date:  2010-08       Impact factor: 2.372

3.  Pharmacokinetics and Pharmacodynamics of Henagliflozin, a Sodium Glucose Co-Transporter 2 Inhibitor, in Chinese Patients with Type 2 Diabetes Mellitus.

Authors:  Xiaolan Yong; Aidong Wen; Xiangyang Liu; Haiyan Liu; Yan-Ping Liu; Nan Li; Tingting Hu; Ying Chen; Minquan Wang; Lantian Wang; Xiaojiao Dai; Juan Huang; Jia Li; Huaqiong Shen
Journal:  Clin Drug Investig       Date:  2016-03       Impact factor: 2.859

4.  The risk allele load accelerates the age-dependent decline in beta cell function.

Authors:  A Haupt; H Staiger; S A Schäfer; K Kirchhoff; M Guthoff; F Machicao; B Gallwitz; N Stefan; H-U Häring; A Fritsche
Journal:  Diabetologia       Date:  2009-01-27       Impact factor: 10.122

Review 5.  The association between the peroxisome proliferator-activated receptor-gamma2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: a HuGE review and meta-analysis.

Authors:  Hebe N Gouda; Gurdeep S Sagoo; Anne-Helen Harding; Jan Yates; Manjinder S Sandhu; Julian P T Higgins
Journal:  Am J Epidemiol       Date:  2010-02-23       Impact factor: 4.897

6.  Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.

Authors:  Anne Flint; Khalil Nazzal; Pawel Jagielski; Charlotte Hindsberger; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

7.  Adaptive genetic variation, stress and glucose regulation.

Authors:  Roxanne C Oriel; Christopher D Wiley; Michael J Dewey; Paul B Vrana
Journal:  Dis Model Mech       Date:  2008-11-06       Impact factor: 5.758

Review 8.  Complexity of type 2 diabetes mellitus data sets emerging from nutrigenomic research: a case for dimensionality reduction?

Authors:  Jim Kaput; Kevin Dawson
Journal:  Mutat Res       Date:  2007-05-05       Impact factor: 2.433

9.  Transcription factor 7-like 2 (TCF7L2) variations associated with earlier age-onset of type 2 diabetes in Thai patients.

Authors:  Watip Tangjittipokin; Nalinee Chongjarean; Nattachet Plengvidhya; Mayuree Homsanit; Pa-Thai Yenchitsomanus
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

10.  Impact of the Pro12Ala polymorphism of the PPAR-Gamma 2 gene on metabolic and clinical characteristics in the Palestinian type 2 diabetic patients.

Authors:  S Ereqat; A Nasereddin; K Azmi; Z Abdeen; R Amin
Journal:  PPAR Res       Date:  2009-10-25       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.